Under the microscope: Focus on Chlamydia pneumoniae infection and multiple sclerosis

Enrico Fainardi, Massimiliano Castellazzi, Silva Seraceni, Enrico Granieri, Carlo Contini

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the Central Nervous System (CNS) of supposed autoimmune origin whose etiology still remains unknown. Epidemiological studies suggest that MS pathogenesis could be related to an infection superimposed on a predisposing genetic background. However, at present, no direct evidence for an infectious implication in MS autoimmunity exists. Recently, the potential role of Chlamydia pneumoniae as a causative agent of MS has received increasing attention. After the initial high rates reported for molecular and culture demonstration of C. pneumoniae in cerebrospinal fluid (CSF) of MS patients, the association between C. pneumoniae and MS was intensively investigated with controversial results. Seroepidemiological reports did not show any strong association between C. pneumoniae infection and the risk of MS. Isolation techniques failed to detect C. pneumoniae in CSF and brain tissue of MS patients. Polymerase chain reaction (PCR) evidence of C. pneumoniae in CSF and intrathecal synthesis of anti-C. pneumoniae IgG have been undetectable in MS patients or, if present, were not selectively associated with MS, but were shared by several inflammatory neurological conditions. Nevertheless, in a subgroup of MS patients, an association between PCR positivity for C. pneumoniae in CSF and disease activity was found. Intrathecal production of anti-C. pneumoniae high-affinity IgG predominated in MS progressive forms and metabolically active C. pneumoniae was identified in CSF. C. pneumoniae was recognized in CSF and brain tissue at immunohistochemical, molecular and ultrastructural levels. C. pneumoniae was also able to induce the animal model of MS. This growing body of data does not support a central role for C. pneumoniae as a candidate in MS pathogenesis, but suggests that, in a subset of MS patients, C. pneumoniae could induce a chronic persistent brain infection acting as a cofactor in the development of the disease. Thus, the actual involvement of C. pneumoniae in MS still remains to be elucidated.

Original languageEnglish
Pages (from-to)60-70
Number of pages11
JournalCurrent Neurovascular Research
Volume5
Issue number1
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Chlamydophila pneumoniae
Chlamydia Infections
Multiple Sclerosis
Cerebrospinal Fluid
CNS Demyelinating Autoimmune Diseases
Brain
Immunoglobulin G
Polymerase Chain Reaction
Infection

Keywords

  • Antibody affinity
  • Cerebrospinal fluid
  • Chlamydia pneumoniae
  • Intrathecal synthesis
  • Magnetic resonance imaging
  • Multiple sclerosis
  • Polymerase chain reaction

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Under the microscope : Focus on Chlamydia pneumoniae infection and multiple sclerosis. / Fainardi, Enrico; Castellazzi, Massimiliano; Seraceni, Silva; Granieri, Enrico; Contini, Carlo.

In: Current Neurovascular Research, Vol. 5, No. 1, 02.2008, p. 60-70.

Research output: Contribution to journalArticle

Fainardi, E, Castellazzi, M, Seraceni, S, Granieri, E & Contini, C 2008, 'Under the microscope: Focus on Chlamydia pneumoniae infection and multiple sclerosis', Current Neurovascular Research, vol. 5, no. 1, pp. 60-70. https://doi.org/10.2174/156720208783565609
Fainardi, Enrico ; Castellazzi, Massimiliano ; Seraceni, Silva ; Granieri, Enrico ; Contini, Carlo. / Under the microscope : Focus on Chlamydia pneumoniae infection and multiple sclerosis. In: Current Neurovascular Research. 2008 ; Vol. 5, No. 1. pp. 60-70.
@article{9af6edd79942468b933717351557b7d2,
title = "Under the microscope: Focus on Chlamydia pneumoniae infection and multiple sclerosis",
abstract = "Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the Central Nervous System (CNS) of supposed autoimmune origin whose etiology still remains unknown. Epidemiological studies suggest that MS pathogenesis could be related to an infection superimposed on a predisposing genetic background. However, at present, no direct evidence for an infectious implication in MS autoimmunity exists. Recently, the potential role of Chlamydia pneumoniae as a causative agent of MS has received increasing attention. After the initial high rates reported for molecular and culture demonstration of C. pneumoniae in cerebrospinal fluid (CSF) of MS patients, the association between C. pneumoniae and MS was intensively investigated with controversial results. Seroepidemiological reports did not show any strong association between C. pneumoniae infection and the risk of MS. Isolation techniques failed to detect C. pneumoniae in CSF and brain tissue of MS patients. Polymerase chain reaction (PCR) evidence of C. pneumoniae in CSF and intrathecal synthesis of anti-C. pneumoniae IgG have been undetectable in MS patients or, if present, were not selectively associated with MS, but were shared by several inflammatory neurological conditions. Nevertheless, in a subgroup of MS patients, an association between PCR positivity for C. pneumoniae in CSF and disease activity was found. Intrathecal production of anti-C. pneumoniae high-affinity IgG predominated in MS progressive forms and metabolically active C. pneumoniae was identified in CSF. C. pneumoniae was recognized in CSF and brain tissue at immunohistochemical, molecular and ultrastructural levels. C. pneumoniae was also able to induce the animal model of MS. This growing body of data does not support a central role for C. pneumoniae as a candidate in MS pathogenesis, but suggests that, in a subset of MS patients, C. pneumoniae could induce a chronic persistent brain infection acting as a cofactor in the development of the disease. Thus, the actual involvement of C. pneumoniae in MS still remains to be elucidated.",
keywords = "Antibody affinity, Cerebrospinal fluid, Chlamydia pneumoniae, Intrathecal synthesis, Magnetic resonance imaging, Multiple sclerosis, Polymerase chain reaction",
author = "Enrico Fainardi and Massimiliano Castellazzi and Silva Seraceni and Enrico Granieri and Carlo Contini",
year = "2008",
month = "2",
doi = "10.2174/156720208783565609",
language = "English",
volume = "5",
pages = "60--70",
journal = "Current Neurovascular Research",
issn = "1567-2026",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Under the microscope

T2 - Focus on Chlamydia pneumoniae infection and multiple sclerosis

AU - Fainardi, Enrico

AU - Castellazzi, Massimiliano

AU - Seraceni, Silva

AU - Granieri, Enrico

AU - Contini, Carlo

PY - 2008/2

Y1 - 2008/2

N2 - Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the Central Nervous System (CNS) of supposed autoimmune origin whose etiology still remains unknown. Epidemiological studies suggest that MS pathogenesis could be related to an infection superimposed on a predisposing genetic background. However, at present, no direct evidence for an infectious implication in MS autoimmunity exists. Recently, the potential role of Chlamydia pneumoniae as a causative agent of MS has received increasing attention. After the initial high rates reported for molecular and culture demonstration of C. pneumoniae in cerebrospinal fluid (CSF) of MS patients, the association between C. pneumoniae and MS was intensively investigated with controversial results. Seroepidemiological reports did not show any strong association between C. pneumoniae infection and the risk of MS. Isolation techniques failed to detect C. pneumoniae in CSF and brain tissue of MS patients. Polymerase chain reaction (PCR) evidence of C. pneumoniae in CSF and intrathecal synthesis of anti-C. pneumoniae IgG have been undetectable in MS patients or, if present, were not selectively associated with MS, but were shared by several inflammatory neurological conditions. Nevertheless, in a subgroup of MS patients, an association between PCR positivity for C. pneumoniae in CSF and disease activity was found. Intrathecal production of anti-C. pneumoniae high-affinity IgG predominated in MS progressive forms and metabolically active C. pneumoniae was identified in CSF. C. pneumoniae was recognized in CSF and brain tissue at immunohistochemical, molecular and ultrastructural levels. C. pneumoniae was also able to induce the animal model of MS. This growing body of data does not support a central role for C. pneumoniae as a candidate in MS pathogenesis, but suggests that, in a subset of MS patients, C. pneumoniae could induce a chronic persistent brain infection acting as a cofactor in the development of the disease. Thus, the actual involvement of C. pneumoniae in MS still remains to be elucidated.

AB - Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the Central Nervous System (CNS) of supposed autoimmune origin whose etiology still remains unknown. Epidemiological studies suggest that MS pathogenesis could be related to an infection superimposed on a predisposing genetic background. However, at present, no direct evidence for an infectious implication in MS autoimmunity exists. Recently, the potential role of Chlamydia pneumoniae as a causative agent of MS has received increasing attention. After the initial high rates reported for molecular and culture demonstration of C. pneumoniae in cerebrospinal fluid (CSF) of MS patients, the association between C. pneumoniae and MS was intensively investigated with controversial results. Seroepidemiological reports did not show any strong association between C. pneumoniae infection and the risk of MS. Isolation techniques failed to detect C. pneumoniae in CSF and brain tissue of MS patients. Polymerase chain reaction (PCR) evidence of C. pneumoniae in CSF and intrathecal synthesis of anti-C. pneumoniae IgG have been undetectable in MS patients or, if present, were not selectively associated with MS, but were shared by several inflammatory neurological conditions. Nevertheless, in a subgroup of MS patients, an association between PCR positivity for C. pneumoniae in CSF and disease activity was found. Intrathecal production of anti-C. pneumoniae high-affinity IgG predominated in MS progressive forms and metabolically active C. pneumoniae was identified in CSF. C. pneumoniae was recognized in CSF and brain tissue at immunohistochemical, molecular and ultrastructural levels. C. pneumoniae was also able to induce the animal model of MS. This growing body of data does not support a central role for C. pneumoniae as a candidate in MS pathogenesis, but suggests that, in a subset of MS patients, C. pneumoniae could induce a chronic persistent brain infection acting as a cofactor in the development of the disease. Thus, the actual involvement of C. pneumoniae in MS still remains to be elucidated.

KW - Antibody affinity

KW - Cerebrospinal fluid

KW - Chlamydia pneumoniae

KW - Intrathecal synthesis

KW - Magnetic resonance imaging

KW - Multiple sclerosis

KW - Polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=39749125544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749125544&partnerID=8YFLogxK

U2 - 10.2174/156720208783565609

DO - 10.2174/156720208783565609

M3 - Article

C2 - 18289023

AN - SCOPUS:39749125544

VL - 5

SP - 60

EP - 70

JO - Current Neurovascular Research

JF - Current Neurovascular Research

SN - 1567-2026

IS - 1

ER -